| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Accounting | 6,800 | 3,400 | 0 | 3,400 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| Denver Life Sciences | AT COST | 100,000 | 100,000 |
| 2400 Sokn Shares | AT COST | 10,008 | 38,904 |
| 30845 Sokn Shares | AT COST | 500,000 | 500,000 |
| 9254 Sokn Shares | AT COST | 150,000 | 150,000 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| Dividends Receivable | 569 | 667 | 667 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Management Fees | 48,613 | 48,613 | 0 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Excise Taxes | 1,105 | |||
| Foreign Taxes | 948 | 948 |